Stock Price
28.20
Daily Change
-0.24 -0.84%
Monthly
3.15%
Yearly
10.59%
Q3 Forecast
28.26

Galapagos reported EUR65.9M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.




Ordinary Share Capital Change Date
argenx SE USD 61.17M 405.3K Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Genmab DKK 10M 56M Mar/2025
Gilead Sciences USD 1.24B 3M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Incyte USD 194.12M 193.93M Jun/2025
Merck EUR 434.78M 130.22M Jun/2025
Neurocrine Biosciences USD 99M 0 Jun/2025
Novartis USD 793M 0 Dec/2024
Roche Holding CHF 107M 0 Jun/2024
Sanofi EUR 1.22B 36.5M Jun/2025
UCB EUR 584M 0 Dec/2024
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025